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AbstrACt
Objective Hospital readmission in patients admitted 
for community-acquired pneumonia (CAP) is frequent 
in the elderly and patients with multiple comorbidities, 
resulting in a clinical and economic burden. The aim of this 
study was to determine factors associated with 30-day 
readmission in patients with CAP.
Design A cross-sectional study.
setting The study was conducted in patients admitted to 
20 hospitals in seven Spanish regions during two influenza 
seasons (2013–2014 and 2014–2015).
Participants We included patients aged ≥65 years 
admitted through the emergency department with a 
diagnosis compatible with CAP. Patients who died during 
the initial hospitalisation and those hospitalised more than 
30 days were excluded. Finally, 1756 CAP cases were 
included and of these, 200 (11.39%) were readmitted.
Main outcome measures 30-day readmission.
results Factors associated with 30-day readmission 
were living with a person aged <15 years (adjusted OR 
(aOR) 2.10, 95% CI 1.01 to 4.41), >3 hospital visits during 
the 90 previous days (aOR 1.53, 95% CI 1.01 to 2.34), 
chronic respiratory failure (aOR 1.74, 95% CI 1.24 to 2.45), 
heart failure (aOR 1.69, 95% CI 1.21 to 2.35), chronic liver 
disease (aOR 2.27, 95% CI 1.20 to 4.31) and discharge 
to home with home healthcare (aOR 5.61, 95% CI 1.70 to 
18.50). No associations were found with pneumococcal or 
seasonal influenza vaccination in any of the three previous 
seasons.
Conclusions This study shows that 11.39% of 
patients aged ≥65 years initially hospitalised for CAP 
were readmitted within 30 days after discharge. 
Rehospitalisation was associated with preventable and 
non-preventable factors.
IntrODuCtIOn  
Community-acquired pneumonia (CAP) is a 
frequent, potentially serious disease in people 
aged ≥65 years and one of the leading causes 
of hospitalisation and mortality worldwide 
in this age group,1–4 in whom recovery from 
an episode of CAP is predictive of increased 
mortality in subsequent years.5 
The incidence of CAP differs between 
European countries due to variations in age 
distribution, the introduction of vaccination 
programmes and the clinical guidelines used. 
However, the incidence of cases and hospital-
isations increases with age in all countries.6 7 
In Spain, CAP is not a reportable disease and 
therefore the incidence in the popula-
tion is unknown, although 2013 data also 
show an increase in hospitalisation (394.04 
per 100,000 in the 65–74 years age group 
and 2584.95 per  100,000 in the >85 years age 
group).8
In people aged ≥65 years, full recovery after 
hospitalisation due to CAP is usually slow and 
the probability of readmission during a period 
of time after discharge is greater.9 Thirty-day 
readmission postdischarge is usually used as 
an indicator of vulnerability.2 10–12
Readmission in patients initially hospital-
ised due to CAP is relatively frequent (espe-
cially in the elderly and patients with multiple 
comorbidities), and is often associated with a 
worsening of a baseline disease or the appear-
ance of a new pathology,13 and this results in 
a significant clinical and economic burden 
for health systems.2 14 Studies have explored 
strengths and limitations of this study
 ► All the information on readmission was obtained 
from medical records.
 ► The study is part of a multicentre study carried out in 
seven autonomous communities representing 70% 
of the Spanish population.
 ► It was not possible to collect detailed information on 
the readmission episode.
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the factors associated with readmission following hospi-
talisation due to CAP, and have identified factors that 
improve the prognosis at discharge and are considered 
preventable, such as influenza and pneumococcal vacci-
nation, the use of hospital care protocols, discharge plan-
ning and postdischarge follow-up. Adequate discharge 
planning, including patient stability and destination, has 
been associated with reduced readmission.15–17 However, 
the effect of seasonal influenza and pneumococcal vacci-
nation and the adequacy of hospital care (use of clinical 
guidelines and antibiotic plans) may be more controver-
sial.18–21 The initial severity of CAP, worsening of comor-
bidities and some individual patient characteristics have 
been described as non-preventable factors,15 21–25 and 
factors such as age, sex, socioeconomic status, education 
and some comorbidities have been independently associ-
ated with a greater likelihood of readmission.25 26
The objective of this study was to determine the risk 
factors associated with 30-day readmission in people aged 
≥65 years initially hospitalised due to CAP.
MAterIAls AnD MethODs
study design
This cross-sectional study was carried out as part of a multi-
centre study in 20 hospitals from seven Spanish regions 
(Andalusia, the Basque Country, Castile and Leon, Cata-
lonia, Madrid, Navarre and Valencian Community). 
Patients aged ≥65 years hospitalised due to CAP in the 
participating hospitals during the 2013–2014 and 2014–
2015 influenza seasons were recruited.
study population
The Spanish health system assigns each citizen a primary 
healthcare centre and a referral hospital to be attended. 
The assignation of the population to each hospital is 
made according to geography. Consequently, if there is a 
readmission, it would be in the same hospital. However, in 
an emergency, the patient may be treated in any hospital.
Patients included were aged ≥65 years admitted 
through the emergency department to any of the partici-
pating hospitals for ≥24 hours with a chest X-ray showing 
pulmonary infiltrate compatible with pneumonia and ≥1 
of the following symptoms or signs of acute lower respira-
tory tract infection: cough, pleural chest pain, dyspnoea, 
fever >38°C, hypothermia <35°C and abnormal auscul-
tator respiratory sounds unexplained by other causes.
Patients who died during the initial hospitalisation 
and patients hospitalised for more than 30 days were not 
included. Institutionalised patients, patients with nosoco-
mial pneumonia (onset ≥48 hours after hospital admis-
sion), patients whose main residence was not in any of 
the seven participating regions and those who did not 
provide signed informed consent were excluded.
Outcomes
The dependent variable was 30-day readmission, defined 
as ‘hospitalisation for any reason within 30 days of 
discharge’. Information on readmission was collected by 
re-review of index hospital medical records up to 30 days 
after initial discharge.
All participating hospitals had a specifically trained 
team of health professionals who used a structured ques-
tionnaire to obtain sociodemographic information and 
lifestyle factors by patient interview and the review of 
patient's medical record to collect immunisation history, 
risk medical conditions and the CAP hospital care process.
Information collected included sociodemographic vari-
ables: age, sex, marital status, educational level, cohabi-
tation; lifestyle factors: smoking status (current smoker, 
ex-smoker, non-smoker) and high alcohol consumption 
(>40 g/day in men, >20 g/day in women). The Barthel 
Index27 was used to assess the functional capacity at 
hospital admission (ranging from 0 — complete depen-
dence to 100 — complete independence). Patients were 
considered vaccinated against pneumococcal disease 
if they had received a dose of pneumococcal vaccine in 
the last 5 years and against seasonal influenza if they had 
received a dose of the influenza vaccination at least 14 
days before symptom onset. Comorbidities considered at 
high or moderate risk (chronic respiratory failure, history 
of pneumonia during the last 2 years, solid or haemato-
logical neoplasm, diabetes mellitus, renal failure, chronic 
obstructive pulmonary disease (COPD), heart failure, 
disabling neurological disease, chronic liver disease and 
haemoglobinopathy or anaemia) were collected from 
the patient's medical record through chart review  and 
were assessed using the Charlson Comorbidity Index,28 
which assigns a weight to each comorbid condition (0, 
no comorbidity; 1, low comorbidity and 2, high comor-
bidity). Number of primary care nurse visits, number of 
hospital visits in the last 90 days. Severity of illness quan-
tified in five risk classes using the Pneumonia Severity 
Index (PSI) at admission,29 length of stay (LOS) <8 and 
≥8 days,8 intensive care unit (ICU) admission, mechan-
ical ventilation, adequacy of antibiotic treatment plan 
according to clinical guidelines (yes/no) and discharge 
disposition (home without services, home with home 
healthcare or social health centre) 6 were also colected
statistical analysis
The Barthel Index, a continuous variable, was dichoto-
mised into 0–89 (moderate-to-high degree of depen-
dency) and ≥90 (little or no dependency).
A bivariate analysis was conducted to compare 30-day 
readmission and no readmission according to sociode-
mographic variables, lifestyle factors, the Barthel Index, 
immunisation history, risk medical conditions, prior 
medical utilisation and hospital care process. Indepen-
dent variables were checked for collinearity using the 
variance inflation factor.30
As Spanish regions have varying degrees of autonomy 
in organising health services, persons living in the same 
region tend to have similar access to healthcare. There-
fore, to estimate the crude OR and adjusted OR (aOR), 
we used multilevel regression models that considered 
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the outcome variable in people from the same region 
to obtain accurate statistical estimates of predictors of 
30-day readmission.30 Covariates were introduced into 
the model using a backward stepwise procedure, with a 
cut-off point of p<0.2.
The analysis was performed using the SPSS V.24 statis-
tical package and R V.3.3.0 statistical software.
results
Overall, 1929 inpatients met all study eligibility criteria 
for CAP: 93 patients died during the initial hospitalisation 
and 80 were hospitalised for >30 days. Therefore, 1756 
CAP cases were discharged within 30 days after the initial 
hospitalisation: of these, 200 (11.39%) were readmitted 
within 30 days after hospital discharge (figure 1).
The reasons for 30-day readmission were unrelated 
to pneumonia in 49.5% (99 cases), pneumonia-related 
in 44.5% (89 cases) and unknown diagnosis in 6% (12 
cases).
The descriptive analysis and unadjusted associations of 
factors related to 30-day readmission are shown in table 1. 
No differences were observed according to lifestyle factors 
and immunisation history.
Factors independently associated with 30-day readmis-
sion in the multilevel analysis (table 2) were living with 
a person aged <15 years (aOR 2.10, 95% CI 1.01 to 4.41; 
p=0.04), more than three hospital visits during the 90 
previous days (aOR 1.53, 95% CI 1.01 to 2.34; p=0.04) 
chronic respiratory failure (aOR 1.74, 95% CI 1.24 to 
2.45; p=0.001), heart failure (aOR 1.69, 95% CI 1.21 to 
2.35; p=0.002), chronic liver disease (aOR 2.27, 95% CI 
1.21 to 4.31; p=0.01) and discharge to home with home 
healthcare (aOR 5.61, 95% CI 1.70 to 18.50; p=0.005).
A moderate-to-high degree of dependency was tenta-
tively associated with readmission (aOR 1.39, 95% CI 0.99 
to 1.95; p=0.05).
No associations were observed with age, sex, pneumo-
coccal vaccination or seasonal influenza vaccination in 
any of the three previous seasons, the PSI or any variable 
related to the hospital care process.
DIsCussIOn
The overall 30-day readmission rate in our study was 
11.39%. Although all participating hospitals were referral 
centres, readmission rates ranged between regions from 
2.5% to 14%. This might be due to the differences in the 
hospital healthcare burden of participating hospitals and 
in the protocols used.
In the Pneumonia Patient Outcomes Research Team 
cohort study, carried out in the USA and Canada, the 
readmission rate in adults was 10.1%.31 Readmission rates 
at 30 days in people aged ≥65 years admitted for CAP vary 
between 8% and 27%, depending on the population and 
country studied.11 19 21 25 32 In Spain, national data show 
30-day readmissions increased from 11.5% in 2004 to 
13.5% in 2013 in adults admitted for CAP.8
Our results show that non-preventable factors, specif-
ically patient characteristics (living with a person aged 
<15 years, more than three hospital visits during the 90 
previous days and some comorbidities) and one prevent-
able factor (discharge disposition) were significantly 
associated with 30-day readmission. Factors such as cohab-
itation and the discharge dispostion have been little 
studied and their identification provides a new perspec-
tive on the risk factors involved in 30-day readmission of 
these patients.
Figure 1 Flow chart of hospital readmissions. CAP, community-acquired pneumonia.
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Table 1 Distribution of 30-day readmission cases according to patient characteristics
Readmission 
n=200 No readmission n=1556 Crude OR (95%CI) P values
Sociodemographic
Age median (range) 80 (65–101) 78 (64–100) 1.02 (0.99–1.04) 0.07
Age group
  65–74 years 56 (28.0%) 501 (32.2%) 1
  75–84 years 98 (49.0%) 729 (46.9%) 1.20 (0.85–1.70) 0.31
  >84 years 46 (23.0%) 326 (20.5%) 1.26 (0.83–1.91) 0.27
Sex
  Female 64 (32.0%) 622 (40.0%) 1
  Male 136 (68.0%) 934 (60.0%) 1.44 (1.05–1.97) 0.02
Educational level
  No/primary education 153 (78.1%) 1118 (72.4%) 1
  Secondary or higher 43 (21.9%) 427 (27.6%) 0.75 (0.51–1.10) 0.14
Marital status
  Married/cohabiting 116 (58.0%) 912 (58.6%) 1
  Single 21 (10.5%) 107 (6.9%) 1.56 (0.94–2.59) 0.09
  Widowed/divorced 63 (31.5%) 536 (34.4%) 0.93 (0.67–1.29) 0.66
Cohabitation
  Lives alone 31 (15.5%) 289 (18.6%) 1
  Lives with cohabitant aged >15 years 155 (77.5%) 1203 (77.4%) 1.20 (0.80–1.80) 0.39
  Lives with cohabitant aged <15 years 14 (7.0%) 63 (4.1%) 2.03 (1.02–4.04) 0.04
Lifestyle factors
Smoking status
  Non-smoker 79 (39.5%) 693 (44.5%) 1
  Smoker 16 (8.0%) 138 (8.9%) 1.04 (0.59–1.83) 0.90
  Ex-smoker 105 (52.5%) 725 (46.6%) 1.28 (0.94–1.75) 0.11
High alcohol consumption
  No 197 (98.5%) 1524 (97.9%) 1
  Yes 3 (1.5%) 32 (2.1%) 1.38 (0.42–4.54) 0.60
Prior utilisation of resources
No of nurse visits in last 90 days
  0–2 147 (73.5%) 1182 (76.4%) 1
  ≥3 53 (26.5%) 365 (23.6%) 1.17 (0.82–1.65) 0.39
No of hospital visits in last 90 days
  0–2 164 (82.8%) 1355 (87.6%) 1
  ≥3 34 (17.2%) 192 (12.4%) 1.53 (1.02–2.31) 0.04
Barthel Index
  Little or no dependency >90 108 (54.0%) 990 (63.6%) 1
  Moderate-to-high dependency ≤90 92 (46.0%) 566 (36.4%) 1.47 (1.08–2.01) 0.01
Immunisations
Influenza vaccination in any of the three previous seasons
  No 54 (27.0%) 464 (29.8%) 1
  Yes 146 (73.0%) 1092 (70.2%) 1.16 (0.83–1.61) 0.39
Pneumococcal vaccination in five previous years
  No 161 (80.5%) 1281 (82.3%) 1
Continued
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Readmission 
n=200 No readmission n=1556 Crude OR (95%CI) P values
  Yes 39 (19.5%) 275 (17.7%) 1.11 (0.76–1.62) 0.58
Risk medical conditions
Chronic respiratory failure
  No 136 (68.0%) 1269 (81.6%) 1
  Yes 64 (32.0%) 287 (18.4%) 2.08 (1.50–2.88) <0.001
Pneumonia during the last 2 years
  No 146 (73.0%) 1267 (81.4%) 1
  Yes 54 (27.0%) 289 (18.6%) 1.65 (1.18–2.32) 0.004
Any malignancy
  No 161 (80.5%) 1271 (81.7%) 1
  Yes 39 (19.5%) 285 (18.3%) 1.08 (0.74–1.58) 0.67
Diabetes
  No 139 (69.5%) 1023 (65.7%) 1
  Yes 61 (30.5%) 533 (34.3%) 0.83 (0.60–1.14) 0.26
Renal failure
  No 151 (75.5%) 1263 (81.2%) 1
  Yes 49 (24.5%) 293 (18.8%) 1.38 (0.97–1.96) 0.07
Chronic obstructive pulmonary disease
  No 128 (64.0%) 1074 (69.0%) 1
  Yes 72 (36.0%) 482 (31.0%) 1.25 (0.92–1.70) 0.16
Heart failure
  No 128 (64.0%) 1168 (75.1%) 1
  Yes 72 (36.0%) 388 (24.9%) 1.69 (1.24–2.31) 0.001
Chronic liver disease
  No 186 (93.0%) 1504 (96.7%) 1
  Yes 14 (7.0%) 52 (3.3%) 2.13 (1.15–3.94) 0.01
Haemoglobinopathy or anaemia
  No 160 (80.0%) 1324 (85.1%) 1
  Yes 40 (20.0%) 232 (14.9%) 1.40 (0.96–2.04) 0.08
Disabling neurological disease
  No 179 (89.5%) 1416 (91.0%) 1
  Yes 21 (10.5%) 140 (9.0%) 1.17 (0.72–1.90) 0.52
Charlson Index
  No comorbidity (0) 18 (9.0%) 233 (15.0%) 1
  Low comorbidity (1) 54 (27.0%) 378 (24.3%) 1.83 (1.05–3.20) 0.03
  High comorbidity (≥2) 128 (64.0%) 945 (60.7%) 1.71 (1.02–2.86) 0.04
Hospital care process
Intensive care unit
  No 188 (94.5%) 1499 (96.9%) 1
  Yes 11 (5.5%) 48 (3.1%) 1.93 (0.97–3.81) 0.06
Mechanical ventilation
  No 157 (78.5%) 1317 (84.9%) 1
  Yes 43 (21.5%) 235 (15.1%) 1.50 (1.03–2.18) 0.03
Pneumonia Severity Index
Table 1 Continued 
Continued
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Calvillo-King et al in a thorough review of studies on 
readmission, underlined the importance of considering 
social factors (sociodemographic, socioeconomic and 
the social environment) as elements that could influ-
ence readmission after an episode of CAP.22 Our study 
evaluated sociodemographic and socioeconomic factors 
and the social environment. Although the influence of 
sex varies between studies and may be closely related to 
other factors such as age, risk habits and some comorbidi-
ties, the association with male sex disappeared in the final 
model, in contrast to the results found by Neupane et al, 
and Bohannon and Maljanian.19 33
Patients living with children aged <15 years had a twofold 
higher probability of readmission than those living alone 
or with a partner. Although it is known that school chil-
dren may be a source of infection of the elderly in some 
infectious diseases, we found no studies that investigated 
the type of cohabitation in this context, possibly because 
one factor usually associated with readmission in people 
aged ≥65 years is living in geriatric residences.11 In Spain, 
the recommendation of vaccination of persons in contact 
with high-risk persons, including persons aged ≥65 years 
with risk factors has been maintained.34 We also found 
no association with factors identified by other authors, 
such as the educational level or the history of smoking or 
alcohol use.25 35
In the studies by Neupane et al in two Canadian cities 
and Adamuz et al in a tertiary hospital in Barcelona, 
seasonal influenza and pneumococcal vaccination were 
included in the adjusted analysis of readmission due to 
CAP, but no association was found.19 23 We investigated 
seasonal influenza and pneumococcal vaccination in the 
previous 5 years but found no association in the crude or 
adjusted models.
In our study, 49.5% of 30-day readmissions were due to 
causes unrelated to CAP and 91% of readmitted patients 
presented comorbidities. Patients with chronic liver 
disease, heart failure and respiratory failure had higher 
Readmission 
n=200 No readmission n=1556 Crude OR (95%CI) P values
  I–III 69 (34.7%) 645 (41.7%) 1
  IV–V 130 (65.3%) 902 (58.3%) 1.40 (1.02–1.92) 0.04
Length of hospital stay
  <8 days 80 (40.0%) 766 (49.2%) 1
  ≥8 days 120 (60.0%) 790 (50.8%) 1.45 (1.05–2.02) 0.02
Antibiotic treatment
  No 97 (50.3%) 700 (46.6%) 1
  Yes 96 (49.7%) 802 (53.4%) 1.07 (0.76–1.50) 0.70
Discharge disposition
  Home without services 185 (92.5%) 1477 (94.9%) 1
  Home with home healthcare 9 (4.5%) 19 (1.2%) 5.05 (1.58–16.15) 0.01
  Social health centre 6 (3.0%) 60 (3.9%) 1.23 (0.41–2.92) 0.63
Table 1 Continued 






Age 1.02 (0.99–1.04) 0.13
Sex—male 1.39 (0.99–3.12) 0.06
Cohabitation
  Lives alone 1









  Married/cohabiting 1
  Single 1.73 (0.96–3.11) 0.07
  Widowed/divorced 0.94 (0.61–1.44) 0.77
  No of hospital visits ≥3 1.53 (1.01–2.34) 0.04
Barthel Index
  Moderate-to-high 
dependency ≤90 1.39 (0.99–1.95)
0.05
  Pneumonia during the last 
2 years
1.31 (0.91–1.88) 0.14
  Chronic respiratory failure 1.74 (1.24–2.45) 0.001
  Diabetes 0.74 (0.53–1.04) 0.08
  Heart failure 1.69 (1.21–2.35) 0.002
  Chronic liver disease 2.27 (1.20–4.31) 0.01
  Mechanical ventilation 1.33 (0.90–1.97) 0.15
Discharge disposition
  Home without services 1
  Home with home healthcare 5.61 (1.70–18.50) 0.005
  Social health centre 1.27 (0.53–3.05) 0.59
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30-day readmission rates, findings consistent with other 
studies showing that some cardiovascular and respiratory 
diseases play an important role in the risk of readmis-
sion in patients with CAP,12 23–25 36 and that the reason for 
readmission generally differs from the initial diagnosis of 
CAP due, in most cases, to destabilisation of comorbid-
ities10 23–26 37 38. Fine et al, in a cohort study, found that 
pneumonia often occurs in patients with underlying 
comorbidities and often results in a worsening of such 
underlying conditions.31
We found an association with prior hospital utilisation 
in the 90 days before admission for CAP, but no associ-
ation with general practitioner and primary care nurse 
visits. Healthcare in Spain is free, which encourages 
patients to make multiple visits to primary care centres 
and/or hospitals, ensuring patient care and follow-up. 
Adamuz et al and Tang et al found an association between 
readmission and hospitalisation in the 90 days before 
admission for CAP.11 23
One preventable factor that influences CAP episodes 
in people aged ≥65 years is the quality of care received 
during hospitalisation, while discharge planning and 
follow-up until recovery influence patient recovery and, 
therefore, readmission.16 21 23 24 We found, as did Dong 
et al,16 an association with discharge to home with home 
healthcare. A possible explanation might be an inad-
equate evaluation of the patient’s stability at discharge. 
Various authors have suggested the importance of the 
discharge dispostion in patients admitted due to other 
causes such as COPD or some specific interventions.39–41 
However, with respect to patients with CAP, only Dong 
et al and the present study have found an association 
between the discharge dispostion and readmission. Other 
variables related to the quality of care were studied to 
assess these aspects but no association with readmission 
was found.
strengths and limitations
The main strength of the study is that all clinical infor-
mation was obtained from patient medical records and, 
therefore, was unlikely to be biased. Another strength is 
the cross-sectional design, as it is part of a multicentre 
study carried out in seven regions representing 70% of 
the Spanish population.
A limitation is that it was not possible to collect patient 
characteristics at discharge, and therefore we cannot 
say whether there was instability at discharge that may 
have caused the readmission. Therefore, the variable 
‘discharge disposition’ was considered as a proxy to 
define instability.
COnClusIOns
In conclusion, this study shows that 11.39% of patients 
aged ≥65 years hospitalised due to CAP are readmitted 
within 30 days after an episode of CAP and that this was 
associated with living with a cohabitant aged <15 years, 
more than three hospital visits during the 90 previous 
days, chronic respiratory failure, heart failure, chronic 
liver disease and discharge to home with home health-
care services.
Because social factors, in addition to postdischarge and 
prereadmission clinical information, may influence the 
prognosis, it is important that these factors continue to 
be considered in future research.
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